|
Diagnostic tests OraSure thing. Oral specimen kits and other diagnostic tests developed by OraSure Technologies are designed to detect HIV and drug use. The firm's OraSure products use oral specimens rather than traditional blood- or urine-based methods to test for HIV. Its Intercept line uses oral samples to test for marijuana, cocaine, opiates, PCP, and amphetamines. The firm has also developed a rapid HIV blood diagnostic testing method. OraSure sells its products in the US and internationally through direct agents and independent distributors, primarily to public health clinics, hospitals, and doctors' offices.
|
| | | Contact Information | |
Address: |
220 E. 1st St.
Bethlehem, PA 18015-1360
| | Phone: | 610-882-1820 | | Fax: | 610-882-1830 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 71.10 M | | Revenue Growth (1 yr): | (-14.00%) | | Employees (2008): | 287 | | Employee Growth (1 yr): | (-1.00%) |
|
|
Key People
| | • |
Chairman:
Douglas G. Watson
| | • |
President, CEO, and Director:
Douglas A. Michels
| | • |
CFO, COO, and Director:
Ronald H. (Ron) Spair
|
|
|
